No Data
Earnings Call Summary | VolitionRX(VNRX.US) Q1 2024 Earnings Conference
The following is a summary of the VolitionRx Limited (VNRX) Q1 2024 Earnings Call Transcript:Financial Performance:VolitionRx reported Q1 revenue of approximately $170,000, a 15% increase compared to
Express News | VolitionRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Sales Results
VolitionRX | 10-Q: Quarterly report
VolitionRX 1Q Rev $170,000 >VNRX
VolitionRX 1Q Rev $170,000 >VNRX
Express News | VolitionRX Ltd: Cost Reduction Measures Underway With a Target of $10 Mln in Annualized Reductions
Express News | VolitionRX Limited Announces First Quarter 2024 Financial Results and Business Update